Dimethylamine

Dimethylamine

SCHEMBL4418002

CNC.Cc1c(Cc2ccccc2)ccc2c(CCC3CCN(C(=O)O)CC3)noc12

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACHE P22303 20/20 0.47
BCHE P06276 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL4131682 0.90 KDM4E (0.46) ACHEBCHE
Dimethylamine SCHEMBL4114208 0.88 ACHE (0.49) ACHEBCHE
Dimethylamine SCHEMBL4126994 0.87 ACHE (0.40) ACHEBCHE
Dimethylamine SCHEMBL4121726 0.86 ACHE (0.42) ACHEBCHE
Dimethylamine SCHEMBL4121165 0.86 ACHE (0.44) ACHEBCHE
SCHEMBL4114424 0.86 ACHE (0.47) ACHEBCHE
SCHEMBL4120426 0.85 ACHE (0.46) ACHEBCHE
Dimethylamine SCHEMBL4127224 0.85 ACHE (0.40) ACHEBCHE
Dimethylamine SCHEMBL4125717 0.85 ACHE (0.41) ACHEBCHE
Dimethylamine SCHEMBL4121108 0.84 ACHE (0.41) ACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318690-A1 Benzisoxazole Compound NR1I2, NR1I3, NR0B1 ACHE 3716/4885BCHE 2215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.